All Type of News
Pharma related industries likely to fall victim to hard times
A variety of industries relating to pharmaceutical facility and equipment, raw materials and printing are taking a direct hit from the latest government’s plan to cut drug prices as pharmaceutical firms are moving to ...
M&As, restructuring to sweep pharmaceutical industry
The government’s plan to cut prices for drugs covered by health insurance by an average of 17 percent will make it harder for companies to do business.
Analysts expect a large number of mergers and acquisitions (M&...
Will Kwangdong’s Vita 500 revenue be affected by new Bacchus F?
Dong-A Pharmaceutical announced on August 22 that it would revive the production of Bacchus-F - discontinued in 2005 - by reopening its shuttered factory in Daegu and supplying the product directly to non-pharmacy ret...
Pharmaceutical firms go all-out for cash
The government’s merciless drug price cuts have promoted pharmaceutical companies to seek more cash to meet the uncertain future.
"Companies are vying to secure cash as the growing liquidity preference has become t...
Falling drug prices increase people’s medication burden
Retail drug prices are expected to fall about 17 percent on average beginning next year following a set of government-led reforms.
However, pharmaceutical firms have denounced government-led price reduction measure...
Novotech conducts multinational study for THVD-201 in Korea
The U.S.-based TheraVida, Inc., a privately-held California biopharmaceutical company, has announced the start of a Phase 2 clinical trial of its lead product candidate THVD-201 for the treatment of overactive bladder...
Dong-A to market GSK’s Polident
Dong-A Pharmaceutical is expected to re-establish a marketing and distribution partnership with GloxoSmithKline Healthcare.
Under the deal, Dong-A will sell Polident, denture cleanser and Sensodyne, toothpaste bran...
Health insurance to cover new botanical drug for osteoporosis
The Ministry of Health and Welfare said Monday that the national health insurance will cover Green Cross Corp.’s Shinbaro capsule, a new botanical drug for osteoporosis treatment, from next month.
Sinbaro capsule, ...
Drug makers hold negative view on drug re-categorization
Pharmaceutical companies expressed a negative view toward the idea of re-categorizing medicines as part of measures to reduce customers' inconvenience in buying drugs and strengthen monitoring of drug use.
The reac...
Pharmaceutical companies seeking tie-ups over development of anti-obesity drugs
Now that the prevalence of obesity has been increasing at an alarming rate over the past few years, not only in the industrialized nations, but also in the developing ones, the focus of government agencies and pharmac...
